[1] |
COUCHMAN L,MONIZ C F.Analytical considerations for the biochemical assessment of vitamin D status[J]. Ther Adv Musculoskeletal Dis,2017,9(4):97-104.
|
[2] |
LE GOFF C,SOUBERBIELLE J C,DELVIN E,et al.Vitamin D measurement: pre-analytical and analytical considerations[J]. Ann Biol Clini(Paris),2015,73(1):79-92.
|
[3] |
CECCATO F,BOSCARO M.Cushing's syndrome: screening and diagnosis[J]. High Blood Press Cardiovasc Prev,2016,23(3):209-215.
|
[4] |
HIRSH S,BEN-DOR A.Finding a needle in a haystack: the advantages of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in determination of sex hormones in children[J]. Pediatr Endocrinol Rev,2016,13(4):714-719.
|
[5] |
WANG Q, MESAROS C,BLAIR I A,et al.Ultra-high sensitivity analysis of estrogens for special populations in serum and plasma by liquid chromatography-mass spectrometry:assay considerations and suggested practices[J]. J Steroid Biochem Mol Biol,2016,162:70-79.
|
[6] |
AUCELLA F,LAURIOLA V,VECCHIONE G,et al.Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant[J]. J Pharm Biomed Anal,2013,86:123-126.
|
[7] |
GHAREEB M,AKHLAGHI F.Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS[J]. Bioanalysis,2015,7(8):1037-1058.
|
[8] |
EZGU F.Inborn errors of metabolism[J]. Adv Clin Chem,2016,73:195-250.
|
[9] |
OMBRONE D,GIOCALIERE E,FORNI G,et al.Expanded newborn screening by mass spectrometry:new tests,future perspectives[J]. Mass Spectrom Rev,2016,35(1):71-84.
|
[10] |
ANGELETTI S.Matrix assisted laser desorption time of flight mass spectrometry (MALDI-TOF MS) in clinical microbiology[J]. J Microbiol Methods,2017,138:20-29.
|
[11] |
CHENG K,CHUI H,DOMISH L,et al.Recent development of mass spectrometry and proteomics applications in identification and typing of bacteria[J].Proteomics Clin Appl,2016,10(4):346-357.
|
[12] |
SHEN Y,TOLI N,PIEHOWSKI P D,et al.High-resolution ultrahigh-pressure long column reversed-phase liquid chromatography for top-down proteomics[J]. J Chromatogr A, 2017,1498:99-110.
|
[13] |
SHI T,SONG E,NIE S,et al.Advances in targeted proteomics and applications to biomedical research[J]. Proteomics,2016,16(15-16):2160-2182.
|
[14] |
BODEAU-LIVINEC F,GLORENNEC P,COT M,et al. Elevated blood lead levels in infants and mothers in benin and potential sources of exposure[J]. Int J Environ Res Public Health,2016,13(3):pii:E316.
|
[15] |
PEREZ A L,NEMBHARD M,MONNOT A,et al.Child and adult exposure and health risk evaluation following the use of metal- and metalloid-containing costume cosmetics sold in the United States[J]. Regul Toxicol Pharmacol,2017,84:54-63.
|
[16] |
MARCINKOWSKA M,BARAŁKIEWICZ D. Multielemental speciation analysis by advanced hyphenated technique-HPLC/ICP-MS:a review[J]. Talanta,2016,161:177-204.
|
[17] |
唐古生,吴豫,沈茜. 免疫检测干扰因素的分析、识别和对策[J]. 中华检验医学杂志,2009,32(7):725-729.
|
[18] |
CHACE D H,KALAS T A.A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing[J]. Clin Biochem,2005,38(4):296-309.
|
[19] |
CHEN Y,YAZDANPANAH M,HOFFMAN B R,et al.Rapid determination of serum testosterone by liquid chromatography-isotope dilution tandem mass spectrometry and a split sample comparison with three automated immunoassays[J]. Clin Biochem,2009,42(6):484-490.
|
[20] |
HARING R,BAUMEISTER S E,NAUCK M,et al.Testosterone and cardiometabolic risk in the general population-the impact of measurement method on risk associations: a comparative study between immunoassay and mass spectrometry[J]. Eur J Endocrinol,2013,169(4):463-470.
|
[21] |
FRENCH D.Advances in bioanalytical techniques to measure steroid hormones in serum[J]. Bioanalysis,2016,8(11):1203-1219.
|
[22] |
KEEVIL B G.LC-MS/MS analysis of steroids in the clinical laboratory[J]. Clin Biochem, 2016,49(13-14):989-997.
|
[23] |
BEDNER M,LIPPA K A,TAI S S.An assessment of 25-hydroxyvitamin D measurements in comparability studies conducted by the Vitamin D Metabolites Quality Assurance Program[J]. Clin Chim Acta,2013,426:6-11.
|
[24] |
ENKO D,FRIDRICH L,REZANKA E,et al.25-Hydroxy-vitamin D status:limitations in comparison and clinical interpretation of serum-levels across different assay methods[J]. Clin Lab,2014,60(9):1541-1550.
|
[25] |
MOREAU E,BÄCHER S,MERY S,et al. Performance characteristics of the VIDAS® 25-OH vitamin D total assay-comparison with four immunoassays and two liquid chromatography-tandem mass spectrometry methods in a multicentric study[J]. Clin Chem Lab Med,2016,54(1):45-53.
|
[26] |
SPANAUS K,VON ECKARDSTEIN A.Evaluation of two fully automated immunoassay based tests for the measurement of 1α,25-dihydroxyvitamin D in human serum and comparison with LC-MS/MS[J]. Clin Chem Lab Med,2017,55(9):1305-1314.
|
[27] |
VOLMER D A,MENDES L R,STOKES C S.Analysis of vitamin D metabolic markers by mass spectrometry:current techniques,limitations of the "gold standard" method,and anticipated future directions[J]. Mass Spectrom Rev, 2015,34(1):2-23.
|
[28] |
TAYLOR P J.Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry[J]. Ther Drug Monit,2004,26(2):215-219.
|
[29] |
TAYLOR P J,TAI C H,FRANKLIN M E,et al.The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs[J]. Clin Biochem,2011,44(1):14-20.
|
[30] |
DASGUPTA A.Impact of interferences including metabolite crossreactivity on therapeutic drug monitoring results[J]. Ther Drug Monit, 2012,34(5):496-506.
|
[31] |
SOLDIN S J,STEELE B W,WITTE D L,et al.Lack of specificity of cyclosporine immunoassays. Results of a College of American Pathologists Study[J]. Arch Pathol Lab Med,2003,127(1):19-22.
|
[32] |
DELAFIORI J,RING G,FUREY A.Clinical applications of HPLC-ICP-MS element speciation:a review[J]. Talanta,2016,153:306-331.
|
[33] |
NETZEL B C,GRANT R P,HOOFNAGLE A N,et al.First steps toward harmonization of LC-MS/MS thyroglobulin assays[J]. Clin Chem,2016,62(1):297-299.
|
[34] |
ANTUNES M V,CHARÃO M F,LINDEN R. Dried blood spots analysis with mass spectrometry:potentials and pitfalls in therapeutic drug monitoring[J]. Clin Biochem,2016,49(13-14):1035-1046.
|
[35] |
WAGNER M,TONOLI D,VARESIO E,et al.The use of mass spectrometry to analyze dried blood spots[J]. Mass Spectrom Rev,2016,35(3):361-438.
|
[36] |
BAKER T C,HAN J,BORCHERS C H.Recent advancements in matrix-assisted laser desorption/ionization mass spectrometry imaging[J]. Curr Opin Biotechnol,2017,43:62-69.
|
[37] |
BADU-TAWIAH A K,EBERLIN L S,OUYANG Z
|
|
et al. Chemical aspects of the extractive methods of ambient ionization mass spectrometry[J]. Annu Rev Phys Chem,2013,64:481-505.
|
[38] |
FLINDERS B,CUYPERS E,ZEIJLEMAKER H
|
|
et al. Preparation of longitudinal sections of hair samples for the analysis of cocaine by MALDI-MS/MS and TOF-SIMS imaging[J]. Drug Test Anal,2015,7(10):859-865.
|
[39] |
ANNESLEY T M,MCKEOWN D A,HOLT D W,et al.Standardization of LC-MS for therapeutic drug monitoring of tacrolimus[J]. Clin Chem,2013,59(11):1630-1637.
|
[40] |
JOHNSON-DAVIS K L,JUENKE J M,THOMAS R L.et al. Everolimus method comparison between Waters MassTrakTM Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients[J]. Ann Clin Lab Sci,2015,45(1):27-31.
|
[41] |
FERREIRA C R,YANNELL K E,JARMUSCH A K,et al.Ambient ionization mass spectrometry for point-of-care diagnostics and other clinical measurements[J]. Clin Chem,2016,62(1):99-110.
|